|
🐜
|
The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
61 auth.
C. Bladen,
D. Salgado,
S. Monges,
M. Foncuberta,
K. Kekou,
K. Kosma,
H. Dawkins,
Leanne Lamont,
A. Roy,
T. Chamova,
V. Guergueltcheva,
S. Chan,
L. Korngut,
C. Campbell,
Y. Dai,
...
Jen Wang,
N. Barišić,
P. Brabec,
J. Lahdetie,
M. Walter,
O. Schreiber-Katz,
V. Karcagi,
M. Garami,
V. Viswanathan,
Farhad Bayat,
F. Buccella,
E. Kimura,
Z. Koeks,
J. C. van den Bergen,
M. Rodrigues,
R. Roxburgh,
A. Lusakowska,
A. Kostera-Pruszczyk,
J. Zimowski,
Rosário Santos,
E. Neagu,
S. Artemieva,
V. Rašić,
D. Vojinovic,
M. Posada,
C. Bloetzer,
P. Jeannet,
F. Joncourt,
J. Díaz-Manera,
E. Gallardo,
A. Karaduman,
H. Topaloğlu,
R. El Sherif,
A. Stringer,
A. Shatillo,
Ann S. Martin,
H. Peay,
M. Bellgard,
J. Kirschner,
K. Flanigan,
V. Straub,
K. Bushby,
J. Verschuuren,
A. Aartsma-Rus,
C. Béroud,
Hanns Lochmüller
|
9 |
2015 |
9
🐜
|
|
🐜
|
Long-lasting treatment effect of rituximab in MuSK myasthenia
13 auth.
J. Díaz-Manera,
E. Martínez-Hernandez,
L. Querol,
R. Klooster,
R. Rojas‐García,
X. Suárez-Calvet,
J. Muñoz-Blanco,
C. Mazia,
K. Straasheijm,
E. Gallardo,
...
C. Juárez,
J. Verschuuren,
I. Illa
|
8 |
2012 |
8
🐜
|
|
🐜
|
Population-based incidence and prevalence of facioscapulohumeral dystrophy
9 auth.
J. C. Deenen,
Hisse Arnts,
S. M. van der Maarel,
G. Padberg,
J. Verschuuren,
E. Bakker,
...
S. Weinreich,
A. Verbeek,
B. V. van Engelen
|
8 |
2014 |
8
🐜
|
|
🐬
|
The Epidemiology of Neuromuscular Disorders: A Comprehensive Overview of the Literature.
J. C. Deenen,
C. Horlings,
J. Verschuuren,
A. Verbeek,
B. V. van Engelen
|
7 |
2015 |
7
🐬
|
|
🐬
|
SOX1 antibodies are markers of paraneoplastic Lambert–Eaton myasthenic syndrome
L. Sabater,
M. Titulaer,
A. Saiz,
J. Verschuuren,
A. Gure,
F. Graus
|
7 |
2008 |
7
🐬
|
|
🐜
|
Epidemiology of inclusion body myositis in the Netherlands: A nationwide study
16 auth.
U. Badrising,
M. Maat-Schieman,
S. V. Duinen,
F. Breedveld,
P. Doorn,
B. Engelen,
F. V. D. Hoogen,
J. Hoogendijk,
C. Höweler,
A. D. Jager,
...
F. Jennekens,
P. Koehler,
H. Leeuw,
M. Visser,
J. Verschuuren,
A. Wintzen
|
7 |
2000 |
7
🐜
|
|
🐢
|
Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS.
16 auth.
M. Titulaer,
P. Maddison,
J. Sont,
P. Wirtz,
D. Hilton‐Jones,
R. Klooster,
N. Willcox,
M. Potman,
P. Smitt,
J. Kuks,
...
B. Roep,
A. Vincent,
S. M. van der Maarel,
J. V. van Dijk,
B. Lang,
J. Verschuuren
|
7 |
2011 |
7
🐢
|
|
🐜
|
Quantitative MRI and strength measurements in the assessment of muscle quality in Duchenne muscular dystrophy
10 auth.
B. Wokke,
J. V. D. Bergen,
M. Versluis,
E. Niks,
Julien Milles,
Andrew G. Webb,
...
E. Zwet,
A. Aartsma-Rus,
J. Verschuuren,
H. Kan
|
7 |
2014 |
7
🐜
|
|
🐢
|
Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1
10 auth.
E. Niks,
Y. V. Leeuwen,
M. Leite,
F. Dekker,
A. Wintzen,
P. Wirtz,
...
A. Vincent,
M. V. Tol,
C. M. J. Zijde,
J. Verschuuren
|
7 |
2008 |
7
🐢
|
|
🐢
|
Strong association of MuSK antibody–positive myasthenia gravis and HLA-DR14-DQ5
9 auth.
E. Niks,
J. Kuks,
B. Roep,
G. Haasnoot,
W. Verduijn,
B. Ballieux,
...
M. D. Baets,
A. Vincent,
J. Verschuuren
|
7 |
2006 |
7
🐢
|
|
🦁
|
Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration
7 auth.
J. Verschuuren,
Linda C. Chuang,
M. Rosenblum,
F. Lieberman,
A. Pryor,
J. Posner,
...
J. Dalmau
|
7 |
1996 |
7
🦁
|
